Valenti L - Search Results

1

Correction to: Usefulness of Fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity.

Lombardi R, La Mura V, Cespiati A, Iuculano F, Sigon G, Pallini G, Proietti M, Motta I, Montinaro B, Fiorelli E, Cesari M, Bandera A, Valenti L, Peyvandi F, Montano N, Baldini M, Fracanzani AL. Lombardi R, et al. Among authors: valenti l. Intern Emerg Med. 2022 Sep;17(6):1751. doi: 10.1007/s11739-022-03056-z. Intern Emerg Med. 2022. PMID: 35864374 Free PMC article. No abstract available.

2

Hereditary hemochromatosis in a patient with congenital dyserythropoietic anemia.

Fargion S, Valenti L, Fracanzani AL, Sampietro M, Cappellini MD, Scaccabarozzi A, Soligo D, Mariani C, Fiorelli G. Fargion S, et al. Among authors: valenti l. Blood. 2000 Nov 15;96(10):3653-5. Blood. 2000. PMID: 11071669 Free article.

3

Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis.

Fargion S, Valenti L, Dongiovanni P, Scaccabarozzi A, Fracanzani AL, Taioli E, Mattioli M, Sampietro M, Fiorelli G. Fargion S, et al. Among authors: valenti l. Blood. 2001 Jun 15;97(12):3707-12. doi: 10.1182/blood.v97.12.3707. Blood. 2001. PMID: 11389006 Free article.

4

Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.

Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G. Fargion S, et al. Among authors: valenti l. Am J Gastroenterol. 2001 Aug;96(8):2448-55. doi: 10.1111/j.1572-0241.2001.04052.x. Am J Gastroenterol. 2001. PMID: 11513189

5

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease.

Valenti L, Fracanzani AL, Dongiovanni P, Santorelli G, Branchi A, Taioli E, Fiorelli G, Fargion S. Valenti L, et al. Gastroenterology. 2002 Feb;122(2):274-80. doi: 10.1053/gast.2002.31065. Gastroenterology. 2002. PMID: 11832442

6

Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance.

Valenti L, Fracanzani AL, Fargion S. Valenti L, et al. Gastroenterology. 2003 Mar;124(3):866; author reply 866-7. doi: 10.1053/gast.2003.50130. Gastroenterology. 2003. PMID: 12612935 No abstract available.

7

Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.

Valenti L, Dongiovanni P, Fracanzani AL, Santorelli G, Fatta E, Bertelli C, Taioli E, Fiorelli G, Fargion S. Valenti L, et al. Dig Liver Dis. 2003 Mar;35(3):172-8. doi: 10.1016/s1590-8658(03)00025-2. Dig Liver Dis. 2003. PMID: 12779071

8

TNFalpha promoter polymorphisms.

Fargion S, Valenti L, Dongiovanni P, Fracanzani AL. Fargion S, et al. Among authors: valenti l. Methods Mol Med. 2004;98:47-58. doi: 10.1385/1-59259-771-8:047. Methods Mol Med. 2004. PMID: 15064432

9

Treatment choices for people infected with HCV.

Fargion S, Fracanzani AL, Valenti L. Fargion S, et al. Among authors: valenti l. J Antimicrob Chemother. 2004 May;53(5):708-12. doi: 10.1093/jac/dkh170. Epub 2004 Apr 8. J Antimicrob Chemother. 2004. PMID: 15073158 Review.

10

Searching for coeliac disease in patients with non-alcoholic fatty liver disease.

Bardella MT, Valenti L, Pagliari C, Peracchi M, Farè M, Fracanzani AL, Fargion S. Bardella MT, et al. Among authors: valenti l. Dig Liver Dis. 2004 May;36(5):333-6. doi: 10.1016/j.dld.2004.01.012. Dig Liver Dis. 2004. PMID: 15191202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

565 results

Search Page